RESTEM acquires umbilical cord lining stem cells (ULSCs) technology rights in full to include all intellectual property of such, previous studies and any/all research & development previously completed on ULSCs.
RESTEM acquires umbilical cord lining stem cells (ULSCs) technology rights in full to include all intellectual property of such, previous studies and any/all research & development previously completed on ULSCs.